| The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification AWG of the International, IAN Network, DC Cattran, R Coppo, HT Cook, ... Kidney international 76 (5), 534-545, 2009 | 1234 | 2009 |
| Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria P Ruggenenti, A Perna, G Gherardi, G Garini, C Zoccali, M Salvadori, ... The Lancet 354 (9176), 359-364, 1999 | 1174 | 1999 |
| Sirolimus for Kaposi's sarcoma in renal-transplant recipients G Stallone, A Schena, B Infante, S Di Paolo, A Loverre, G Maggio, ... New England Journal of Medicine 352 (13), 1317-1323, 2005 | 1150 | 2005 |
| The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility AWG of the International, IAN Network, ISD Roberts, HT Cook, S Troyanov, ... Kidney international 76 (5), 546-556, 2009 | 999 | 2009 |
| Pathogenetic mechanisms of diabetic nephropathy FP Schena, L Gesualdo Journal of the American society of nephrology 16 (3_suppl_1), S30-S33, 2005 | 860 | 2005 |
| Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial FP Schena, MD Pascoe, J Alberu, M del Carmen Rial, R Oberbauer, ... Transplantation 87 (2), 233-242, 2009 | 694 | 2009 |
| Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review GFM Strippoli, M Craig, JJ Deeks, FP Schena, JC Craig Bmj 329 (7470), 828, 2004 | 513 | 2004 |
| IgA nephropathy KN Lai, SCW Tang, FP Schena, J Novak, Y Tomino, AB Fogo, ... Nature reviews Disease primers 2 (1), 1-20, 2016 | 493 | 2016 |
| IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23 AG Gharavi, Y Yan, F Scolari, FP Schena, GM Frasca, GM Ghiggeri, ... Nature genetics 26 (3), 354-357, 2000 | 452 | 2000 |
| Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy C Manno, GFM Strippoli, L Arnesano, C Bonifati, N Campobasso, ... Kidney international 66 (4), 1570-1577, 2004 | 441 | 2004 |
| Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy C Manno, DD Torres, M Rossini, F Pesce, FP Schena Nephrology Dialysis Transplantation 24 (12), 3694-3701, 2009 | 406 | 2009 |
| Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or … T Tatsumi, LS Kierstead, E Ranieri, L Gesualdo, FP Schena, JH Finke, ... The Journal of experimental medicine 196 (5), 619-628, 2002 | 404 | 2002 |
| A retrospective analysis of the natural history of primary IgA nephropathy worldwide FP Schena The American journal of medicine 89 (2), 209-215, 1990 | 395 | 1990 |
| The number, quality, and coverage of randomized controlled trials in nephrology GFM Strippoli, JC Craig, FP Schena Journal of the American Society of Nephrology 15 (2), 411-419, 2004 | 382 | 2004 |
| Epidemiology of IgA nephropathy: a global perspective FP Schena, I Nistor Seminars in nephrology 38 (5), 435-442, 2018 | 374 | 2018 |
| A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients F Vincenti, FP Schena, S Paraskevas, IA Hauser, RG Walker, J Grinyo, ... American journal of transplantation 8 (2), 307-316, 2008 | 360 | 2008 |
| The Italian experience of the national registry of renal biopsies L Gesualdo, AM Di Palma, LF Morrone, GF Strippoli, FP Schena Kidney international 66 (3), 890-894, 2004 | 321 | 2004 |
| Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology. FP Schena Nephrology, dialysis, transplantation: official publication of the European …, 1997 | 321 | 1997 |
| Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal H Kreis, R Oberbauer, JM Campistol, T Mathew, P Daloze, FP Schena, ... Journal of the American Society of Nephrology 15 (3), 809-817, 2004 | 306 | 2004 |
| Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials HJL Heerspink, T Greene, H Tighiouart, RT Gansevoort, J Coresh, ... The lancet Diabetes & endocrinology 7 (2), 128-139, 2019 | 304 | 2019 |
